Determination of sample stability for a broad panel of coagulation parameters and factor assays on the Cobas t 711 analyzer starting from fresh-never-frozen plasma
- PMID: 40248435
- PMCID: PMC12003954
- DOI: 10.3389/fmolb.2025.1491239
Determination of sample stability for a broad panel of coagulation parameters and factor assays on the Cobas t 711 analyzer starting from fresh-never-frozen plasma
Abstract
Background: Preanalytical procedures can affect the accuracy of coagulation assay results. Recommended plasma storage temperatures and durations need to be defined for individual coagulation assays. Here, we evaluated the effect of commonly applied plasma storage conditions for a broad panel of 23 basic coagulation parameters as well as specialized factor assays developed for the Cobas® t 711 analyzer (Roche Diagnostics International Ltd., Rotkreuz, Switzerland).
Methods: This single-center, prospective, observational study used anonymized, residual, platelet-poor plasma samples as well as pseudonymized plasma samples to obtain rare ranges of certain analytes. Fresh-never-frozen plasma samples processed within 4 h were tested in triplicate at time zero (t0), with measurements repeated at various predefined timepoints after storage at 18-25°C, 2-8°C, or under freezing and deep freezing. Mean deviation from t0, expressed as a percentage or as absolute change in signal at very low analyte levels, was assessed against predefined, assay-specific acceptance criteria for each analyte.
Results: The sample stability results under the examined storage conditions for all 23 assays met or exceeded the requirements for routine laboratory coagulation testing and the respective acceptance criteria for each individual assay were fulfilled. Fresh-never-frozen samples were used to reflect real-life laboratory settings, enabling the early detection of out-of-specification results.
Conclusion: Sample stability was determined for a broad panel of assays on the t 711 analyzer, for application in routine coagulation testing practice.
Keywords: Cobas t 711 analyzer; blood coagulation; coagulation testing; fresh-never-frozen plasma; sample stability; storage duration; temperature.
Copyright © 2025 Hoffmann, Gottschalk, Huber, Scheling, von Allmen and Hegel.
Conflict of interest statement
MH and NG are employees of Roche Diagnostics GmbH and hold non-voting equity securities of F. Hoffmann-La Roche. PH is an employee of Roche Diagnostics International Ltd. and holds non-voting equity securities of F. Hoffmann-La Roche. JKH, NvA, and VS are employed by Labor Berlin – Charité Vivantes Services GmbH. The authors declare that this study received funding from Roche Diagnostics GmbH, Penzberg, Germany. The funder had the following involvement with the study: conception and design; acquisition, analysis, and interpretation of data. Third-party medical writing assistance was funded by Roche Diagnostics International Ltd. (Rotkreuz, Switzerland).
Similar articles
-
Effects of frozen storage conditions and freezing rate on the stability of coagulation proteins in human plasma.Blood Coagul Fibrinolysis. 2023 Sep 1;34(6):377-384. doi: 10.1097/MBC.0000000000001239. Epub 2023 Jul 19. Blood Coagul Fibrinolysis. 2023. PMID: 37577899
-
Determining the effect of freezing on coagulation testing: comparison of results between fresh and once frozen-thawed plasma.Blood Coagul Fibrinolysis. 2015 Jan;26(1):69-74. doi: 10.1097/MBC.0000000000000184. Blood Coagul Fibrinolysis. 2015. PMID: 25202883
-
Stability of coagulation parameters in plasma samples at room temperature after one freeze/thaw cycle.Int J Lab Hematol. 2022 Jun;44(3):610-618. doi: 10.1111/ijlh.13794. Epub 2022 Jan 13. Int J Lab Hematol. 2022. PMID: 35029031
-
Performance of 6 routine coagulation assays on the new Roche Cobas t711 analyzer.Pract Lab Med. 2019 Nov 9;17:e00146. doi: 10.1016/j.plabm.2019.e00146. eCollection 2019 Nov. Pract Lab Med. 2019. PMID: 31799361 Free PMC article.
-
System performance evaluation of the cobas t 711 and cobas t 511 coagulation analyzers in routine laboratory settings.Blood Coagul Fibrinolysis. 2020 Oct;31(7):459-468. doi: 10.1097/MBC.0000000000000947. Blood Coagul Fibrinolysis. 2020. PMID: 32826393 Free PMC article.
References
-
- Adcock D. M., Hoefner D. M., Kottke-Marchant K., Marlar R. A., Szamosi D. I., Warunek D. J. (2008). Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays; approved guideline. Fifth Edition. H21-A5 edn. Wayne, PA, USA: Clinical and Laboratory Standards Institute of Medicine.
-
- Bertsch T., Behringer W., Blaschke S., Body R., Davidson S., Müller-Olling M., et al. (2023). Deep vein thrombosis and pulmonary embolism: a prospective, observational study to evaluate diagnostic performance of the Tina-quant D-Dimer Gen.2 assay. Front. Cardiovasc Med. 10, 1142465. 10.3389/fcvm.2023.1142465 - DOI - PMC - PubMed
-
- Favaloro E., Adcock D., Lippi G. (2012). Pre-analytical variables in coagulation testing associated with diagnostic errors in hemostasis. Lab. Med. 43, 1–10. 10.1309/LM749BQETKYPYPVM - DOI
LinkOut - more resources
Full Text Sources
Miscellaneous